Serum insulin-like growth factor I regulates brain amyloid-beta levels. - Wikidata - awgldk - TriplyDB

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

http://www.wikidata.org/entity/Q48454367

about

Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease Humanin: a novel central regulator of peripheral insulin action Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death Aging as an event of proteostasis collapse Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease Obesity Reduces Cognitive and Motor Functions across the Lifespan IGF-I: A Key Growth Factor that Regulates Neurogenesis and Synaptogenesis from Embryonic to Adult Stages of the Brain Human conditions of insulin-like growth factor-I (IGF-I) deficiency Aberrant insulin signaling in Alzheimer's disease: current knowledge A Concerted Action Of Estradiol And Insulin Like Growth Factor I Underlies Sex Differences In Mood Regulation By Exercise.Senescence (ageing) @ 2011 Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?POTENTIAL NON-GROWTH USES OF rhIGF-I Reduced IGF-1 signaling delays age-associated proteotoxicity in mice Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model.Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration.Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor.Estrogen: a master regulator of bioenergetic systems in the brain and body Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice.Activation of proteasome by insulin-like growth factor-I may enhance clearance of oxidized proteins in the brain.Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.Insulin action in brain regulates systemic metabolism and brain function.Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels The p75 neurotrophin receptor localization in blood-CSF barrier: expression in choroid plexus epithelium Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach 17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.Reducing Igf-1r levels leads to paradoxical and sexually dimorphic effects in HD mice.Thyroid hormones are associated with poorer cognition in mild cognitive impairment.Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles Presenilin-1 regulates induction of hypoxia inducible factor-1α: altered activation by a mutation associated with familial Alzheimer's disease The effect of insulin and insulin-like growth factors on hippocampus- and amygdala-dependent long-term memory formation Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease.CARDIOVASCULAR RISK FACTORS AFFECT HIPPOCAMPAL MICROVASCULATURE IN EARLY AD.A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3

P2860

Q21129438-2088080C-EFC3-4D5B-AA82-ABCFF1077007 Q21562384-DC79A225-D32C-4C3F-9994-E705001FC11D Q24297908-DD972989-8B0E-4A65-A01D-37AB49A76B32 Q24606199-F27D707F-C233-4D0E-90A4-0680677AC92F Q24630961-ACE240F8-732B-4154-B4AE-64FE1F06C8E7 Q24798001-FDE1B165-FF78-4AFF-8506-7E76103D14C4 Q26765753-24231714-16A2-4470-BB9E-26A482B47E7D Q26768613-C8690257-52CD-4B10-9F68-B5EED6DA1A63 Q26822806-F54BD5D7-2D73-4823-8951-9A961FEFC454 Q27024222-F7EC952B-CC92-4352-B4D2-18C23F7EA5D1 Q27315057-458288FE-2BB8-41A7-B161-CBAD4BB45024 Q28732158-2FD9C483-1CEB-45A9-A0C3-CA3CBBDE9FB2 Q30275974-8C98EE5A-49DE-4D68-819E-AC70C66EE4C5 Q30492205-CC9DA77E-F82F-4A50-B386-90D2FE5F607D Q30497845-077625A6-0E81-492B-B463-46061337FE3A Q30506148-231C392C-2E40-422D-8773-769A30F33CC6 Q30575876-3548B017-E1DD-44ED-9621-EC0D3E15AE2E Q30634663-BF1617FC-38DC-435F-9E06-7A84D4A896DC Q33264215-2DA55D79-A6D4-4146-8952-B800CA775628 Q33358106-79EDD018-C875-49DA-891A-3508D68EA601 Q33623924-19CD63C7-A385-4E54-83DA-80BDFD7312FE Q33647486-8C0D1516-D741-4AB2-B136-522CDC831EAB Q33651979-77256E78-D681-42D9-968A-B5F27BC80DBE Q33737093-98DBE4A8-14C3-4E7A-8799-E8EA6F604779 Q33789365-DF62E79C-13AF-4340-BD33-2FCBDBB7BCBA Q33838291-168EBBE8-DABE-424D-BEDE-3A8CAF3A8E03 Q33885228-CE735602-721D-4387-8781-27DAE1CE9438 Q33898614-DB079029-71C9-4A19-9F27-A4AB325FB00B Q33925323-6E12EE20-E4FD-4614-BA72-D59E9FD9D32E Q33927741-9EAD4DD4-1A7C-45A7-8C8A-A4757C78E545 Q33936233-167AD73D-9B29-48A0-A000-5F00B71563C1 Q34055011-5834EF3E-86AE-4B0B-86FE-36D32F350D1F Q34070946-87732100-61AA-4048-8A40-B58AF8238B23 Q34168826-C20A87C8-DEFF-403A-B8A2-D82313BF4148 Q34185639-AFB54156-1D91-4213-9418-7D4C895B4ABF Q34203028-89A67CB6-E6C5-4F95-A5E3-12583D312589 Q34245876-E2E432C8-2D15-499C-913D-156EEF324652 Q34360055-34B197BC-4971-4C4A-AFDC-7BB975959CE7 Q34575537-2A790258-46EB-481A-B7FD-BFB83B2F6C0B Q34597879-0A7164D5-95A6-4A3D-A83F-61F9A0DE926D

P2860

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

http://www.wikidata.org/entity/Q48454367

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

@en

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

@nl

type

label

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

@en

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

@nl

prefLabel

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

@en

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

@nl

P1433

Q48454367-FC0DF19C-EE65-4402-967B-0E4DB1EFC74B

P1476

Q48454367-255B167F-CE87-41E1-994A-1D16AC7676D7

P2093

Q48454367-30F82F5C-AF4E-4723-906A-9B4CC2577AB7

Q48454367-49FE1416-6ABC-4225-BD7C-42BE44D40514

Q48454367-B372F6BD-EC80-458C-9F12-6E0CE1BCE5B9

P2860

Q48454367-0A94A18F-94F1-4E07-AAF6-EECEDBA1D185

Q48454367-0E0BB9F3-2D3F-41A9-B5A3-92BB3DF2F14D

Q48454367-17B88463-7746-453C-85BF-5EB6BDD3C05D

Q48454367-1A5077B0-18AB-4D2D-94A0-EF97BDF98E4A

Q48454367-1E9AF1CF-6EE0-4BDC-8114-8BC236CE30E8

Q48454367-39925700-2AF7-4FAD-A56A-4ED6E08EF93E

Q48454367-3E07B114-6308-4625-82D3-4F495C9791A6

Q48454367-3EE36269-CD82-494B-A888-75E2CEBEE3D0

Q48454367-52532DC4-535B-4F46-86C3-08F0EC8E14D4

Q48454367-5A389A8A-286C-4A30-970F-B73935F46A2B

P2888

Q48454367-942085DE-2285-4B66-A712-FF577624C045

P304

Q48454367-8AC7CBD1-27D8-4506-90CC-FFAB6CEEEE17

P31

Q48454367-2438ABA3-99FD-4A93-9199-133CACDB156E

P356

Q48454367-AE687303-4449-4F62-B5DD-D88286319AAD

P407

Q48454367-012ABFBC-74CC-4700-8117-25E2337923F4

P433

Q48454367-A098022B-BB3F-40AE-9456-9E4BDA3F8C54

P478

Q48454367-E75D6E17-386F-4210-94B5-80DD1E62F999

P50

Q48454367-3C972AF7-DEBE-40F9-91BF-EDD4148A2B7E

Q48454367-6F1B1D21-D1E7-4CE5-B64B-76466818965D

P577

Q48454367-3A90FBCF-641D-4C40-AB36-10ADCB3F4462

P698

Q48454367-B1E9A7B1-31EC-4E1A-BD8D-EBFBC8A0584E

P921

Q48454367-8E193DFF-7E5F-4871-ABB6-3307A0450E5C

P356

P1433

Nature Medicine

P1476

Serum insulin-like growth factor I regulates brain amyloid-beta levels.

@en

P2093

Gomez-Isla T

http://www.w3.org/2001/XMLSchema#string

Torres-Aleman I

http://www.w3.org/2001/XMLSchema#string

Trejo JL

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide.

The cell biology of the blood-brain barrier.

Insulin-Like growth factor I: implications in aging.

Clearing the brain's amyloid cobwebs.

Aging and proinflammatory cytokines.

A conserved regulatory system for aging.

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

Cubilin, a multifunctional epithelial receptor: an overview.

Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia.

P2888

P304

1390-1397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1202-793

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12415260

http://www.w3.org/2001/XMLSchema#string

P921